Investigation of the potential application of sodium bentonite as an excipient in formulation of sustained release tablets

被引:13
作者
Alkrad, Jamal Alyoussef [1 ]
Abu Shmeis, Reham [1 ]
Alshwabkeh, Iyad [1 ]
Abazid, Husam [2 ]
Mohammad, Mohammad Amin [1 ,3 ]
机构
[1] Isra Univ, Fac Pharm, POB 22 & 23, Amman, Jordan
[2] Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Amman, Jordan
[3] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England
关键词
Direct compression; Sustained release; Excipients; Sodium bentonite; DIRECT COMPRESSION; MONTMORILLONITE; WATER;
D O I
10.1016/j.ajps.2017.01.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the application of sodium bentonite (SB) in formulation of tablets prepared by direct compression for oral administration was tested. Three different model drugs with different solubilities: paracetamol, diclofenac sodium and metformin HCl were tested. Each drug was mixed with SB at ratio of 50% and the mixtures were subsequently compressed. Compatibility studies were conducted using both Deferential Scanning Calorimeter (DSC) and Fourier Transform Infrared Spectroscopy (FTIR). The dissolution profile for each drug was determined in USP-buffers at different time intervals. Diclofenac sodium in pH 6.8 buffer and paracetamol in both pH 6.8 and pH 4.5 buffers showed extended release. However, metformin HCl showed immediate release at the different pH values. The study showed that using SB was possible to prepare tablets with different release profiles. However, these profiles differ depending on dissolution media and drug type. (C) 2017 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:259 / 265
页数:7
相关论文
共 24 条
[1]  
Alderborn G., 2007, AULTONS PHARM DESIGN, P442
[2]  
[白慧东 BAI Hui-dong], 2010, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V30, P394
[3]  
Bendou S., 2014, Journal of Minerals and Materials Characterization and Engineering, V02, P404, DOI [10.4236/jmmce.2014.25045, DOI 10.4236/JMMCE.2014.25045]
[4]   Development of poly(2-hydroxyethyl methacrylate)/clay composites as drug delivery systems of paracetamol [J].
Bounabi, Leila ;
Mokhnachi, Naima Bouslah ;
Haddadine, Nabila ;
Ouazib, Farid ;
Barille, Regis .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2016, 33 :58-65
[5]  
Council of Europe, 2003, EUROPEAN PHARMACOPOE
[6]  
Doldan C, INT J PHARM
[7]  
Gohel MC, 2005, J PHARM PHARM SCI, V8, P76
[8]  
Jivraj Mira, 2000, Pharmaceutical Science and Technology Today, V3, P58, DOI 10.1016/S1461-5347(99)00237-0
[9]   Controlled release formulation of ranitidine-containing montmorillonite and Eudragit® E-100 [J].
Joshi, Ghanshyam V. ;
Kevadiya, Bhavesh D. ;
Bajaj, Hari C. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (09) :1046-1053
[10]  
KHAN KA, 1973, CAN J PHARM SCI, V8, P1